Bortezomib maintenance therapy in newly diagnosed patients with mantle cell lymphoma, responsive on rituximab combined with CHOP and high dose Ara-C and after BEAM with auto PSCT rescue.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Bortezomib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 08 Dec 2015 Status changed from recruiting to completed, as per results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 27 May 2009 New trial record